The value of the global Microfluidics Market is projected to be US$ 3,800.4 Mn in 2018 and to increase to US$ 12,927.6 Mn by the end of 2027.
Over the forecast period, a high prevalence rate of lifestyle diseases is anticipated to fuel market expansion for microfluidics. For instance, 500 million individuals globally had type 2 diabetes in 2018, according to a report by the American Diabetes Association titled "Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)".
Miniaturisation, integration, and automation of priceless complicated chemical, biological, and physical assays are further factors that are anticipated to support market expansion. Due to advantages including decreased sample and reagent consumption, shorter analysis times, simplicity of automation, and the ability to run parallel tests, which reduces assay costs and time, microfluidics systems are a useful tool for biological and chemical assays.
Leading Companies in the Microfluidic Industry:
1. Agilent Technologies: Agilent, which was first separated from Hewlett-Packard in 1999, has grown into a major player in the life sciences and diagnostics industries. With its three operating segments—life science and applied tools, cross lab (containing of consumables and services connected to life science and applied tools), and diagnostics and genomics—Agilent's measuring solutions currently serve a wide range of clients. Founded 1999. Agilent's U.S. headquarters purchases artificial intelligence technology to boost lab productivity.
2. PerkinElmer Inc.: Revvity serves the pharmaceutical, biomedical, chemical, environmental, and general industrial markets with tools, tests, services, and software. There are two business segments. Built in 1937. United States headquarters. In a $2.45 billion deal, PerkinElmer sells three business segments.
3. Thermo Fisher Scientific Inc.: Thermo Fisher Scientific sells reagents for life sciences, laboratory supplies, and equipment for diagnostics. Built in 1956. United States headquarters. The acquisition of The Binding Site Group by Thermo Fisher Scientific is now complete.
4. Qiagen NV: DNA, RNA, and proteins can be extracted, purified, amplified, and interpreted using Qiagen's unique sample and assay technologies. The company's sales are split roughly evenly between molecular diagnostics and applications in the life sciences. Established in 1984. Headquarters in Germany's Hilden. QIAGEN buys the majority of BLIRT S.A., an enzymes supplier.
5. Bio-Rad Laboratories, Inc.: With its headquarters in Hercules, California, Bio-Rad Laboratories creates, produces, and sells goods and services for the clinical diagnostics and life sciences industries. Bio-Rad produces, markets, and maintains test systems and specialised quality controls for clinical laboratories in the diagnostics sector (53% of revenue). Built in 1952. United States headquarters.
6. Abbott Laboratories,: Abbott Laboratories is a medical device and health care company based in America. It was founded in the year 1888 by Wallace Calvin Abbott. The headquarters are located in Abbott Park, Illinois, U.S. The company sells medical devices, branded generic medicines and nutritional products. Abbott’s products include MitraClip, FreeStyle Libre, Pedialyte, Ensure.
7. F. Hoffmann-La Roche Ltd: Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. United States headquarters. For $449 million, Roche buys the biotech company Inflazome.
Definition: Microfluidics refers to a system that manipulates a small amount of fluids using small channels with sizes ten to hundreds micrometres.
